January 20, 2025 - 22:01

In a recent episode of the Opening Bid podcast, Gargi Chaudhuri, the chief investment and portfolio strategist for the Americas at BlackRock, shared her outlook on the stock market for 2025. Chaudhuri emphasized the importance of focusing on "quality" investments, suggesting that investors should prioritize companies with strong fundamentals, solid balance sheets, and sustainable competitive advantages.
She highlighted that economic conditions and market dynamics are expected to evolve significantly over the next few years. As a result, a discerning approach to stock selection will be crucial. Chaudhuri pointed out that companies demonstrating resilience in the face of market volatility will likely outperform their peers.
Moreover, she encouraged investors to remain vigilant and adaptable, as shifts in interest rates and inflation could impact market performance. By maintaining a focus on quality and long-term growth potential, investors can position themselves for success in the evolving landscape of the 2025 stock market.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...